AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,605,152 | -2.7% | 394,980 | +0.0% | 2.06% | +6.3% |
Q2 2023 | $28,376,364 | +35.1% | 394,884 | +16.0% | 1.94% | +21.6% |
Q1 2023 | $20,997,722 | +35.9% | 340,430 | +70.0% | 1.60% | +18.0% |
Q4 2022 | $15,445,591 | +96.9% | 200,254 | +44.5% | 1.35% | +147.3% |
Q1 2021 | $7,846,000 | -53.6% | 138,571 | -33.2% | 0.55% | -58.1% |
Q4 2020 | $16,901,000 | +26.3% | 207,452 | +10.5% | 1.30% | -9.8% |
Q3 2020 | $13,378,000 | +625.9% | 187,756 | +738.2% | 1.45% | +286.6% |
Q2 2020 | $1,843,000 | -44.9% | 22,401 | -60.6% | 0.37% | -42.5% |
Q1 2020 | $3,342,000 | +159.9% | 56,801 | +356.5% | 0.65% | +393.2% |
Q4 2019 | $1,286,000 | – | 12,443 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |